Multiple Sclerosis-Associated Changes in the Composition and Immune Functions of Spore-Forming Bacteria

Area of Science:

• Microbiome research
• Immunology
• Neuroscience

Background:

• Multiple sclerosis (MS) is an autoimmune central nervous system disease with known immune dysregulation.
• Gut microbiota alterations are observed in MS, but mechanistic links remain unclear.
• Spore-forming bacteria (Firmicutes: Bacilli, Clostridia) possess immunomodulatory properties but are understudied in MS.

Purpose of the Study:

• To investigate the community composition and immune function of spore-forming bacteria in MS patients.
• To understand the role of these bacteria in T lymphocyte differentiation and MS pathogenesis.
• To explore potential interactions between spore-forming bacteria and other gut microbes like Akkermansia muciniphila.

Main Methods:

• Computational analysis of microbial communities.
• In vitro studies on T lymphocyte differentiation (IL-10+, IFN-γ+).
• In vivo colonization experiments in antibiotic-treated mice, including induction of experimental allergic encephalomyelitis (EAE).

Main Results:

• MS-associated spore-forming taxa, particularly Clostridia, correlate with impaired IL-10+ regulatory T cell differentiation in vitro.
• Both MS and control-derived spore-forming bacteria induced regulatory T cell responses and ameliorated EAE symptoms in mice.
• Akkermansia muciniphila may exacerbate MS-associated gut microbiota inflammation, potentially interacting with spore-forming bacteria.

Conclusions:

• Alterations in the spore-forming bacterial fraction of the gut microbiota may influence T lymphocyte-mediated inflammation in MS.
• The study highlights the functional importance of specific microbial fractions beyond descriptive analysis.
• This approach of isolating functional microbial subsets can advance the study of microbiome-host interactions in disease.